Onychomycosis: Beyond cosmetic distress

Journal of Cosmetic Dermatology

Volumn 5, Issue 2, 2006, Pages 171-177

  Lateur, Nadine ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Artificial nails; Nail polish; Onychomycosis; Treatment

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT; CICLOPIROX; COSMETIC; FLUCONAZOLE; GRISEOFULVIN; IMIDAZOLE; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ACREMONIUM; ANAMNESIS; ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLUS; CANDIDA ALBICANS; COST EFFECTIVENESS ANALYSIS; DIFFERENTIAL DIAGNOSIS; DRUG BIOAVAILABILITY; DRUG COST; DRUG WITHDRAWAL; EMOTIONAL STRESS; ESTHETICS; FINGERNAIL ONYCHOMYCOSIS; FOOD DRUG INTERACTION; FOOT CARE; FUNGUS CULTURE; FUSARIUM; HEALTH INSURANCE; HUMAN; INDIVIDUALIZATION; MEDICAL SPECIALIST; MICROBIOLOGICAL EXAMINATION; NAIL DISEASE; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RELAPSE; SHOE; TOENAIL ONYCHOMYCOSIS; TREATMENT OUTCOME; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; UNSPECIFIED SIDE EFFECT;

HUMANS; ONYCHOMYCOSIS;

EID: 33745279600     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2006.00246.x     Document Type: Article

References (41)

1. Summerbell RC, Kane J, Krajden S. Onychomycosis, tinea pedis and tinea manuum caused by nondermatophyte filamentous fungi. Mycoses 1989; 32: 609-19.
2. Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol 1996; 35: 539-42.
3. Vander Straten MR, Balkis MM, Ghannoum MA. The role of nondermatophyte molds in onychomycosis: Diagnosis and treatment. Dermatol Ther 2002; 15: 89-98.
4. Haneke E, Roseeuw D. The scope of onychomycosis: Epidemiology and clinical features. Int J Dermatol 1999; 38 (Suppl. 2): 7-12.
5. André J, Achten G. Onychomycosis. Int J Dermatol 1987; 26: 481-90.
6. Sigurgeirsson B, Steingrimsson O. Risk factors associated with onychomycosis. J Eur Acad Dermatol Venereol 2004; 18: 48-51.
7. Lateur N, Mortaki A, André J. Two hundred ninety-six cases of onychomycosis in children and teenagers: A 20-year laboratory survey. Pediatr Dermatol 2003; 20 (5): 385-8.
8. Gupta AK, Lynde CW, Jain HC et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: A multicentre study. Br J Dermatol 1997; 136: 786-9.
9. Gupta AK, Konnikov N, Rich P et al. Prevalence and epidemiology in diabetics: A multicentre study. Br J Dermatol 1998; 139: 665-71.
10. Caputo R, De Boulle K, Del Rosso J et al. Prevalence of superficial fungal infections among sports-active individuals: Results from the Achilles survey, a review of the literature. J Eur Acad Dermatol Venereol 2001; 15: 312-6.
11. Gupta AK, Taborda P, Taborda V et al. Epidemiology and prevalence of onychomycosis in HIV-positive individuals. Int J Dermatol 2000; 39: 746-53.
12. Zaias N, Tosti A, Rebell G et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol 1996; 34: 302-4.
13. Gupta AK, Gupta MA, Summerbell RC et al. The epidemiology of onychomycosis: Possible role of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereol 2000; 14: 466-9.
14. McNeil SA, Foster CL, Hedderwick SA, Kauffman CA. Effect of hand cleansing with antimicrobial soap and alcohol-based gel on microbial colonisation of artificial fingernails worn by health care workers. Clin Infect Dis 2001; 32: 367-72.
15. Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003; 148: 402-10.
16. Millikan LA, Powell DW, Drake LA. Quality of life for patients with onychomycosis. Int J Dermatol 1999; 38 (Suppl. 2): 13-6.
17. Detandt M, Nolard N. Fungal contamination of the floors of swimming pools, particularly subtropical swimming paradises. Mycoses 1995; 38: 509-13.
18. Baran R, Hay RJ, Tosti A, Haneke E. A new classification of onychomycosis. Br J Dermatol 1998; 139: 567-71.
19. Tosti A, Baran R, Piraccini BM, Fanti PA. Endonyx onychomycosis: A new modality of nail invasion by dermatophyte fungi. Acta Derm Venereol 1999; 79 (1): 52-3.
20. Fleckman Ph. Onychomycosis: Diagnosis and topical therapy. Dermatol Ther 2002; 15: 71-7.
21. English MP. Nails and fungi. Br J Dermatol 1976; 94: 697-701.
22. Dordain-Bigot ML, Baran R, Baixench MT, Bazex J. Onychomycose à Fusarium. Ann Dermatol Venereol 1996; 123: 191-3.
23. Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: Clinical features and response to treatment in 59 cases. J Am Acad Dermatol 2000; 42: 217-24.
24. Achten G, Wanet J. Pathologie der nägel. In: VW Schnyder, ed. Histopathologie der Haut. Teil 1. Dermatosen. Berlin, Heidelberg, New York: Springer-VePlag; 1978: pp. 511-53.
25. Lawry MA, Haneke E, Strobeck K, Martin S, Zimmer B, Romano PS. Methods for diagnosing onychomycosis: A comparative study and review of the literature. Arch Dermatol 2000; 136: 1112-6.
26. Reisberger EM, Abels C, Landthaler M, Szeimies RM. Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings. Br J Dermatol 2003; 148 (4): 749-54.
27. Contet-Audonneau N, Salvini O, Basile AM, Percebois G. Les onychomycoses à moisissures. Importance diagnostique de la biopsie unguéale. Fréquence des espèces pathogènes. Sensibilité aux principaux antifongiques. Nouv Dermatol 1995; 14: 330-40.
28. Lateur N, Mortaki A, André J. Onychomycosis in childhood: An update on 296 cases. In: S Ring, S Weindinger, U Darsow, eds. Skin and Environment. Perception and Protection. 10th EADV Congress. Munich, 2001. Bologna: Monduzzi EdPtore, S.p.A.; 2002: pp. 329-34.
29. Bonifaz A, Ibarra G. Onychomycosis in children: Treatment with bifonazole-urea. Pediatr Dermatol 2000; 17: 310-4.
30. Baran R, Kaoukov A. Topical antifungal drugs for the treatment of onychomycosis: An overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol 2005; 19: 21-9.
31. Polak A. The past, present and future of antimycotic combination therapy. Mycoses 1999; 42: 355-70.
32. Gupta AK. Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: A randomized, evaluator-blinded study. J Drugs Dermatol 2005; 4 (4): 481-5.
33. Baran R, Dawber RPR, de Berker DAR. Fungal and other infections involving the nail apparatus: Chemical avulsion. In: Baran and Dawber's Diseases of the Nails and their Management, 3rd edn. Oxford: Blackwell Science; 2001: Pp. 152-3.
34. Zook EG, Baran R, Dawber RPR. Nail surgery and traumatic abnormalities: nail avulsion. In: Baran and Dawber's Diseases of the Nails and their Management, 3rd ednP Oxford: Blackwell Science; 2001: pp. 455-6.
35. De Doncker P. Pharmacokinetics of orally administrated antifungals in onychomycosis. Int J Dermatol 1999; (Suppl. 2): 20-7.
36. Gupta AK, Lambert J. Pharmacoeconomic analysis of the new oral antifungals used to treat toenail onychomycosis in the USA. Int J Dermatol 1999; 38 (Suppl. 2): 53-64.
37. Mackay-Wiggan J, Elewski BE, Scher RK. The diagnosis and treatment of nail disorders: Systemic antifungal therapy. Dermatol Ther 2002; 15: 78-88.
38. Gupta AK, Shear NH. Safety review of the oral antifungal agents used to treat superficial mycoses. Int J Dermatol 1999; 38 (Suppl. 2): 40-52.
39. Zaias N, Rebell G. The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine. Arch Dermatol 2004; 140: 691-5.
40. Gupta AK, Baran R, Summerbell R. Onychomycosis: Strategies to improve efficacy and reduce recurrence. J Eur Acad Dermatol Venereol 2002; 16: 579-86.
41. Roberts DT, Evans EG. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol 1998; 138 (1): 189-90.